The KORA S4/F4 study showed that biomarkers of subclinical inflammation, such as high-sensitivity C-reactive protein and serum amyloid A, were independently associated with 7-year changes in HbA1c before the diagnosis of type 2 diabetes [33]. The gene discussed is CRP; the disease is type 2 diabetes mellitus.